The genomics industry is approaching a fork in the road.
One path leads deeper into probabilistic clinical systems, black-box inference, and decision layers that can drift without anyone fully understanding when, why, or how.
The other leads to deterministic molecular medicine infrastructure.
I believe the future belongs to the second path.
Healthcare does not need more impressive outputs that cannot be governed.
It does not need more clinical ambiguity wrapped in better language.
And it does not need more systems that become harder to trust as they become more sophisticated.
What it needs is infrastructure.
Infrastructure that turns existing genomic and multi-omic data into governed, reproducible, clinically usable intelligence.
Infrastructure where the same input produces the same result.
Infrastructure where findings trace back to source.
Infrastructure that can survive regulation, reimbursement, audit, and real-world consequence.
AI may have a role in the interface layer.
It can help explain, translate, and communicate.
But the clinical core is different.
At the clinical core, trust cannot depend on probability alone.
It cannot depend on drift management.
And it cannot depend on whether a model happens to be behaving well today.
That is why I believe the next real advance in genomics will not come from more data or more models alone.
It will come from building the deterministic molecular medicine layer that should have existed all along.
That is the shift that matters.
